WeightWatchers Stock Soars on FDA Approval of Oral Wegovy
Update: 2025-12-23
Description
WeightWatchers stock surges 14.3% following FDA approval of oral Wegovy, boosting its hybrid weight loss program and setting the stage for a strong January.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
